New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Probi CEO leaves company

Probi CEO leaves company

Michael Oredsson will leave Probi to become CEO of pharmaceutical company BioInvent.

Michael Oredsson will leave as CEO of Probi to take up a position as CEO at listed pharmaceutical company BioInvent. Probi’s vice president of research and development, Gun-Britt Fransson, has been appointed interim CEO. Michael Oredsson will remain at the disposal of Probi until he takes up his new position.

”The Board wants to thank Michael for an excellent contribution since he joined the company in 2007. Under Michael’s leadership, Probi’s revenue has grown from just under MSEK 40 to MSEK 100 whilst establishing robust profitability. We will now recruit a person whose main task will be to continue Probi´s international expansion and broadening of activities with a strengthened focus on R&D” says Per Lundin, Probi’s chairman .

Gun-Britt Fransson has been vice president of research and development at Probi since February 2012. She has held leading positions in the biotech and food industries during the past 20 years. Before she joined Probi, Gun-Britt was CEO at Alligator Bioscience AB in Lund. Prior to that, she was R&D director at Procordia Foods AB and Orkla Foods A.S.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.